Literature DB >> 12354338

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

David M Mannino1, David M Homa, Lara J Akinbami, Earl S Ford, Stephen C Redd.   

Abstract

PROBLEM/CONDITION: Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis and emphysema but has been defined recently as the physiologic finding of nonreversible pulmonary function impairment. This surveillance summary reports trends in different measures of COPD during 1971-2000. REPORTING PERIOD COVERED: This report presents national data regarding objectively determined COPD (1971-1994); COPD-associated activity and functional limitations (1980-1996); self-reported COPD prevalence, COPD physician office and hospital outpatient department visits, COPD hospitalizations, and COPD deaths (1980-2000); and COPD emergency department visits (1992-2000). DESCRIPTION OF SYSTEMS: The Centers for Disease Control's National Center for Health Statistics conducts the National Health Interview Survey annually, which includes questions concerning COPD and activity limitations. The National Center for Health Statistics collects physician office-visit data in the National Ambulatory Medical Care Survey, emergency department and hospital outpatient department data in the National Hospital Ambulatory Medical Care Survey, hospitalization data in the National Hospital Discharge Survey, and death data in the Mortality Component of the National Vital Statistics System. Data regarding pulmonary function were obtained from the National Health and Nutrition Examination Surveys (NHANES) I (1971-1975) and III (1988-1994), and data regarding functional limitation were obtained from NHANES III, Phase 2 (1991-1994).
RESULTS: During 2000, an estimated 10 million U.S. adults reported physician-diagnosed COPD. However, data from NHANES III estimate that approximately 24 million United States adults have evidence of impaired lung function, indicating that COPD is underdiagnosed. During 2000, COPD was responsible for 8 million physician office and hospital outpatient visits, 1.5 million emergency department visits, 726,000 hospitalizations, and 119,000 deaths. During the period analyzed, the most substantial change was the increase in the COPD death rate for women, from 20.1/100,000 in 1980 to 56.7/100,000 in 2000, compared with the more modest increase in the death rate for men, from 73.0/100,000 in 1980 to 82.6/100,000 in 2000. In 2000, for the first time, the number of women dying from COPD surpassed the number of men dying from COPD (59,936 vs 59,118). Another substantial change observed is that the proportion of the population aged < 55 years with mild or moderate COPD, on the basis of pulmonary function testing, decreased from 1971-1975 to 1988-1994, possibly indicating that the upward trends in COPD hospitalizations and mortality might not continue.
INTERPRETATION: COPD is a major cause of morbidity, mortality, and disability in the U.S. Despite its ease of diagnosis, COPD remains an underdiagnosed disease, chiefly in its milder and more treatable form.

Entities:  

Mesh:

Year:  2002        PMID: 12354338

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  96 in total

1.  Comorbidity and chronic conditions in the National Social Life, Health and Aging Project (NSHAP), Wave 2.

Authors:  Terrie Vasilopoulos; Ashwin Kotwal; Megan J Huisingh-Scheetz; Linda J Waite; Martha K McClintock; William Dale
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  Production of decellularized porcine lung scaffolds for use in tissue engineering.

Authors:  Jenna L Balestrini; Ashley L Gard; Angela Liu; Katherine L Leiby; Jonas Schwan; Britta Kunkemoeller; Elizabeth A Calle; Amogh Sivarapatna; Tylee Lin; Sashka Dimitrievska; Stuart G Cambpell; Laura E Niklason
Journal:  Integr Biol (Camb)       Date:  2015-10-01       Impact factor: 2.192

3.  Mucociliary Clearance in Former Tobacco Smokers with Both Chronic Obstructive Pulmonary Disease and Chronic Bronchitis and the Effect of Roflumilast.

Authors:  Beth L Laube; Kathryn A Carson; Gail Sharpless; Laura M Paulin; Nadia N Hansel
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-04-08       Impact factor: 2.849

4.  Health conditions among aging narcotics addicts: medical examination results.

Authors:  Yih-Ing Hser; Lillian Gelberg; Valerie Hoffman; Christine E Grella; William McCarthy; M Douglas Anglin
Journal:  J Behav Med       Date:  2004-12

Review 5.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

6.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 7.  Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.

Authors:  Neil MacIntyre; Yuh Chin Huang
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.

Authors:  Agnieszka Sliwka; Milosz Jankowski; Iwona Gross-Sondej; Monika Storman; Roman Nowobilski; Malgorzata M Bala
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

Review 9.  Treatment of chronic obstructive pulmonary disease in older patients: a practical guide.

Authors:  Abebaw M Yohannes; Christopher C Hardy
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Penalizing hospitals for chronic obstructive pulmonary disease readmissions.

Authors:  Laura C Feemster; David H Au
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.